A pharmaceutical company tested three treatments for migraine headache
sufferers. 72 participants were enrolled in the experiments. The aim is to
examine the potential of new class of treatments in lowering the pain score
associated with the migraine headache episode.
The participants include 36 males and 36 females. Males and females were
further (equally) subdivided into whether they were at low or high risk of
migraine headache.
This data set is suited for three way Anova test.
It is the data set used in the Datanovia tutorial “Three-Way ANOVA in
R: Three Factors and Their Interaction”
(https://www.datanovia.com/learn/biostatistics/anova/three-way-anova-in-r).